BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2014
View Archived Issues
Mission Therapeutics develops new DUB inhibitors
Read More
RIPK3, a potential drug target for Gaucher's disease
Read More
Aduro BioTech presents new vaccine platforms
Read More
GSTM4 gene as a candidate biomarker for eczema herpeticum
Read More
Lilly discloses new homodimeric proteins
Read More
Merck & Co patents new SYK inhibitors
Read More
Ipsen reports findings from phase IIa study of Dysport for neurogenic detrusor overactivity
Read More
New NHE-3 inhibitors patented by Ardelyx and AstraZeneca
Read More
Lupin designs new CaSR agonists
Read More
Cellular Biomedicine Group begins study of stem cell treatment for asthma
Read More
AstraZeneca provides update on global PARTHENON program
Read More
Astellas and Medivation submit sNDA for Xtandi in the U.S.
Read More
Novel HIV-1 maturation inhibitor candidates with improved profile
Read More
Pharma Two B begins phase IIb study of fixed-dose combination therapy P2B-001
Read More
Trovagene introduces NGS-based KRAS oncogene mutation assay
Read More
First patient dosed in phase Ib/II trial of CRLX-101 in rectal cancer
Read More
First patient enrolled in phase II trial of G-202 in glioblastoma multiforme
Read More
FDA extends PDUFA date for Biogen Idec's Plegridy BLA
Read More
Igenica Biotherapeutics doses first patient in phase I study of IGN-523
Read More
Dainippon Sumitomo Pharma presents a novel potent and selective 11beta-HSD1 inhibitor
Read More
Avedro receives FDA complete response letter for corneal cross-linking system
Read More
Advaxis and UCSF to assess cancer immunotherapy constructs
Read More
Medigene licenses RhuDex rights to Dr. Falk Pharma for hepatology and gastroenterology
Read More
Maruho seeks Japanese approval of benzoyl peroxide for acne vulgaris
Read More
Bionomics announces results of phase II trial of BNC-105 in renal cancer
Read More
Peptide triazole KR-13 induces cell-free HIV-1 virolysis
Read More